AGEN peer analysis
Agenus (AGEN) against its competitors: price, today's move, 1-year return and market value side by side.
- AGEN's peers: ABOS (Acumen Pharmaceuticals), FATE (Fate Therapeutics), HURA (TuHURA Biosciences), INO (Inovio Pharmaceuticals), IRD (Opus Genetics), PLRX (Pliant Therapeutics), SEER (Seer), TTRX (Turn Therapeutics).
AGEN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | $0.18 | -9.11% | -88.66% | $12.71M |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |
| HURA TuHURA Biosciences | $1.36 | -0.73% | -22.29% | $89.43M |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| IRD Opus Genetics | $3.87 | -5.17% | 108.01% | $373.95M |
| PLRX Pliant Therapeutics | $0.62 | -6.20% | -58.67% | $38.43M |
| SEER Seer | $1.39 | -3.82% | -30.75% | $77.30M |
| TTRX Turn Therapeutics | $8.64 | -2.81% | 205.30% | $264.15M |
| VTGN Vistagen Therapeutics | $0.19 | -6.47% | -95.85% | $8.62M |
| ZNTL Zentalis | $1.38 | 1.47% | 3.76% | $135.61M |
| AGEN Agenus | $5.90 | -3.91% | 40.48% | $266.95M |